Corbus Pharmaceuticals (NASDAQ:CRBP) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a research note published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, Oppenheimer reissued an outperform rating and issued a $22.00 price objective on shares of Corbus Pharmaceuticals in a research note on Wednesday, August […]

Related Keywords

,Corbus Pharmaceuticals Trading ,News Ratings For Corbus Pharmaceuticals Daily ,Corbus Pharmaceuticals ,Corbus Pharmaceuticals Company Profile ,Corbus Pharmaceuticals Holdings Inc ,Hedge Funds Weigh In On Corbus Pharmaceuticals ,Virtu Financial ,Dimensional Fund Advisors ,Vident Investment Advisory ,Free Report ,Sigma Investments ,Fund Advisors ,Investment Advisory ,State Street Corp ,Street Corp ,Get Free Report ,Pharmaceuticals Holdings ,Corbus Pharmaceuticals Daily ,Nasdaq Crbp ,Crbp ,Medical ,Initiated Coverage ,Stocknews Com ,